Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Gilead Sciences Inc (GILD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart
Realtime quote and/or trade prices are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 95,122,584
  • Shares Outstanding, K 1,306,270
  • Annual Sales, $ 30,390 M
  • Annual Income, $ 13,501 M
  • 36-Month Beta 1.13
  • Price/Sales 3.12
  • Price/Cash Flow 5.76
  • Price/Book 3.75

Price Performance

See More
Period Period Low Period High Performance
1-Month
70.05 +3.44%
on 11/14/17
80.08 -9.52%
on 10/25/17
-7.64 (-9.54%)
since 10/24/17
3-Month
70.05 +3.44%
on 11/14/17
86.27 -16.01%
on 09/08/17
-1.56 (-2.11%)
since 08/24/17
52-Week
63.76 +13.64%
on 06/16/17
86.27 -16.01%
on 09/08/17
-2.84 (-3.77%)
since 11/23/16

Most Recent Stories

More News
J&J & Glaxo's Jucala Approval Puts Spotlight on HIV Space

As HIV and AIDS have limited medical cure but huge medical need, we see how different companies are trying to tap into this huge market.

MYL : 37.37 (+0.24%)
JNJ : 138.01 (+0.52%)
MRK : 54.35 (-0.04%)
ABBV : 94.72 (+0.26%)
GILD : 72.46 (-0.49%)
GSK : 35.04 (-0.06%)
CAR-T Therapy Space 2017 Progress Report

Given the vast potential of the CAR T therapy space and two recent approvals, biotech companies are leaving no stone unturned to develop their pipeline candidates.

CELG : 104.50 (-0.63%)
BLUE : 167.80 (+0.36%)
NVS : 85.08 (+0.71%)
ZIOP : 4.43 (-1.22%)
GILD : 72.46 (-0.49%)
JUNO : 62.85 (+4.18%)
Biotech Poised for Growth: 3 Healthy Fund Choices

The decline in biotech stocks is momentary and we expect the industry to bounce back in the coming days. So consider investing in these three biotech mutual funds.

GILD : 72.46 (-0.49%)
BIPIX : 65.52 (+0.40%)
FBDIX : 147.03 (+0.44%)
FBIOX : 216.10 (+0.54%)
J&J & Glaxo Get FDA Approval for First Two-Drug HIV Regimen

J&J (JNJ) and Glaxo received FDA approval for Juluca, a two-drug complete regimen of Tivicay/rilpivirine and Edurant/dolutegravir as a single tablet for the treatment of HIV-1 infection.

JNJ : 138.01 (+0.52%)
GILD : 72.46 (-0.49%)
PFE : 35.49 (+0.17%)
GSK : 35.04 (-0.06%)
Gilead Sciences to Present at the Nasdaq 37th Investor Program on Wednesday, December 6

Gilead Sciences, Inc. (Nasdaq:GILD) today announced that Kevin Young CBE, Gilead's Chief Operating Officer and Andrew Cheng, Executive Vice President, Clinical Research and Development Operations,...

GILD : 72.46 (-0.49%)
United Therapeutics PAH Drug's Exclusivity Period Extended

United Therapeutics' PAH drug, Adcirca has been granted six months pediatric exclusivity. This will delay generic competition for the drug for an additional six months.

JNJ : 138.01 (+0.52%)
LLY : 84.03 (+0.42%)
GILD : 72.46 (-0.49%)
UTHR : 125.01 (-0.32%)
Celgene CAR-T Therapy Gets Breakthrough Therapy Designation

FDA grants Breakthrough Therapy Designation to Celgene's (CELG) chimeric antigen receptor T-cell (CAR-T) therapy candidate, bb2121.

CELG : 104.50 (-0.63%)
BLUE : 167.80 (+0.36%)
NVS : 85.08 (+0.71%)
GILD : 72.46 (-0.49%)
Biotechs Trading Lower in Q4 on Macro Uncertainty, Tepid Q3

After rising 15.4% in the first nine months of the year, the Medical-Biotech /Genetics industry has declined 13.4% so far in the fourth quarter.

CELG : 104.50 (-0.63%)
VRTX : 146.55 (-0.33%)
ABBV : 94.72 (+0.26%)
GILD : 72.46 (-0.49%)
AMGN : 170.12 (+0.09%)
ALXN : 108.61 (+0.94%)
BIIB : 308.97 (-0.27%)
Today's Research Reports on Trending Tickers: Gilead Sciences and Geron Corporation

NEW YORK, NY / ACCESSWIRE / November 15, 2017 / U.S. markets fell Tuesday on slumping commodity prices, with U.S. crude oil posting its largest one day drop in over a month. The Dow Jones Industrial Average...

GILD : 72.46 (-0.49%)
GERN : 2.01 (+1.52%)
Biotech on the Brink!

This post Biotech on the Brink! appeared first on Daily Reckoning . It’s do-or-die for biotech stocks. Today, Greg Guenthner sets the tone for the final weeks of 2017… The post Biotech on the...

BLUE : 167.80 (+0.36%)
IBB : 312.63 (+0.04%)
GILD : 72.46 (-0.49%)
REGN : 384.85 (-0.69%)
AMGN : 170.12 (+0.09%)
XBI : 81.96 (+0.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators mostly agree with the trend.

See More

Business Summary

Gilead Sciences, Inc. is an independent biopharmaceutical company that seeks to provide accelerated solutions for patients and the people who care for them. They have a broad-based focus on developing and marketing drugs to treat patients with infectious diseases, including viral infections, fungal infections...

See More

Key Turning Points

2nd Resistance Point 73.23
1st Resistance Point 72.84
Last Price 72.46
1st Support Level 72.15
2nd Support Level 71.85

See More

52-Week High 86.27
Fibonacci 61.8% 77.67
Fibonacci 50% 75.01
Last Price 72.46
Fibonacci 38.2% 72.36
52-Week Low 63.76

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart